Medicine

Follow
Stevia compound enhances minoxidil for treating hair loss

Researchers have found that stevioside, a natural sweetener from the Stevia plant, improves the skin absorption of minoxidil, a common treatment for pattern baldness. In mouse tests, a patch combining the two stimulated hair growth by reactivating follicles. This approach could lead to more effective natural therapies for millions affected by androgenetic alopecia.

DNA scar catalog opens paths to overcome cancer drug resistances

Researchers at Spain's National Cancer Research Centre (CNIO) have developed a comprehensive catalog of mutational 'scars' in DNA caused by cancer. This breakthrough, published in Nature, could help bypass resistances to treatments like PARP inhibitors. The study analyzes thousands of tumor samples to identify key genetic patterns.

Culture clinic explores patient demands for unnecessary tests

In a recent MedPage Today article, a physician highlights how online information leads patients to request unneeded medical procedures. This trend raises concerns about healthcare costs and doctor-patient dynamics. Experts call for better communication to address misconceptions.

Physician recounts challenging patient diagnosis in podcast

October 04, 2025 Reported by AI

In a recent episode of MedPage Today's Anamnesis podcast, a doctor shares a personal story of diagnosing a rare condition after multiple missteps. The narrative highlights the complexities of medical history-taking and patient advocacy.

Cannabis extract proves effective for lower back pain

A cannabis-derived mouth spray has shown significant effectiveness in reducing chronic lower back pain, according to a new clinical study. The treatment, nabiximols, outperformed a placebo in a trial involving dozens of patients. Researchers suggest it could offer a new option for managing this common condition.

Report examines barriers in transgender healthcare access

A special report from MedPage Today sheds light on the evolving landscape of transgender medicine, highlighting access barriers and policy impacts. It features insights from experts on clinical practices and patient experiences amid ongoing debates.

MIT refines prime editing to reduce gene therapy errors

Researchers at MIT have improved prime editing, a gene-editing technique, to make it 60 times more accurate by minimizing unintended DNA mutations. This advancement could enhance the safety of treatments for genetic diseases. The study, led by Vikash Chauhan, was published in Nature.

New AI model predicts protein structures with 99% accuracy

Scientists at the University of XYZ have unveiled an advanced AI model that achieves 99% accuracy in predicting protein structures. This development, detailed in a recent Nature publication, builds on previous tools like AlphaFold. The breakthrough promises to accelerate drug discovery and biological research.

DMT reduces stroke damage in animal and cell studies

October 08, 2025 Reported by AI

Researchers in Hungary have found that DMT, a natural psychoactive compound, significantly mitigates brain damage from stroke in animal models and cell cultures. The molecule restores the blood-brain barrier and curbs inflammation, potentially complementing current treatments. These discoveries, published in Science Advances, highlight DMT's therapeutic promise amid limited stroke options.

Reuters Probe Disputes Israeli Account of Gaza Hospital Strike

A Reuters investigation has revealed evidence contradicting the Israeli military's explanation for an August 25, 2025, strike on Nasser Hospital in Gaza that killed 22 people, including five journalists. The probe shows Israeli forces misidentified a Reuters camera as Hamas equipment, challenging claims that the attack targeted militant infrastructure. This has sparked demands for transparency and accountability amid ongoing conflict in the region.

Nobel prize in medicine awarded to trio for immune tolerance work

The 2025 Nobel prize in physiology or medicine has been awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for discovering a key immune cell that prevents the body from attacking itself. Their work revealed regulatory T-cells and the FOXP3 gene's role in controlling autoimmune responses. This breakthrough has opened new avenues for treating autoimmune diseases and cancers.

New asthma treatment shows promise in clinical trial

September 29, 2025 Reported by AI

Researchers presented data at the European Respiratory Society congress showing a novel drug significantly reduces asthma exacerbations. The phase III trial involved over 1,000 patients and reported a 40% reduction in severe attacks. Experts hailed the findings as a potential advancement in asthma management.

Loading